The Caledonian-Record

Biomea Fusion Announces Poster Presentations of Icovamenib at the American Diabetes ...

SAN CARLOS, Calif., May 05, 2026 (GLOBE NEWSWIRE) -- (“Biomea” or “Biomea Fusion” or “the Company”) (Nasdaq: BMEA), a clinical-stage diabetes and obesity company, today announced that ...